Treatment study of hospital acquired pneumonia by optimizing dosing regimen of piperacillin/tazobactam:prolonged vs. regular infusion
Lu Y, Yan Z, Wang DH, Dong WL, Yang Y, Xia R
 
 
Record Status
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Bibliographic details
Lu Y, Yan Z, Wang DH, Dong WL, Yang Y, Xia R. Treatment study of hospital acquired pneumonia by optimizing dosing regimen of piperacillin/tazobactam:prolonged vs. regular infusion. Chinese Critical Care Medicine 2013; 25(8): 479-483
PubMedID
24021044
DOI
10.3760/cma.j.issn.2095-4352.2013.08.008
Indexing Status
Subject indexing assigned by NLM
MeSH
Aged; Anti-Bacterial Agents /administration & Cross Infection /drug therapy; Drug Administration Schedule; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid /administration & Piperacillin /administration & Pneumonia, Bacterial /drug therapy; Prospective Studies; derivatives /blood /therapeutic use; dosage /analogs & dosage /blood /therapeutic use; dosage /blood /therapeutic use
AccessionNumber
22014032090
Date bibliographic record published
05/02/2015
 
NHS Economic Evaluation Database (NHS EED)
Produced by the Centre for Reviews and Dissemination
Copyright © 2026 University of York
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for NHS EED database users